Home > Publications database > CD8 agonism functionally activates memory T cells and enhances antitumor immunity > print |
001 | 180150 | ||
005 | 20241220120851.0 | ||
024 | 7 | _ | |a 10.1002/ijc.34059 |2 doi |
024 | 7 | _ | |a 0020-7136 |2 ISSN |
024 | 7 | _ | |a 1097-0215 |2 ISSN |
024 | 7 | _ | |a altmetric:128805270 |2 altmetric |
024 | 7 | _ | |a pmid:35499751 |2 pmid |
037 | _ | _ | |a DKFZ-2022-01137 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Madi, Alaa Abdelghani Mohamed |0 P:(DE-He78)f05eabc961bc296c088b3510d6429d02 |b 0 |e First author |u dkfz |
245 | _ | _ | |a CD8 agonism functionally activates memory T cells and enhances antitumor immunity |
260 | _ | _ | |a Bognor Regis |c 2022 |b Wiley-Liss |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1698998092_23208 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #EA:D192#LA:D192# / 2022 Sep 1;151(5):797-808 / HI-TRON |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Weisshaar, Nina |0 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0 |b 1 |u dkfz |
700 | 1 | _ | |a Buettner, Michael |b 2 |
700 | 1 | _ | |a Poschet, Gernot |b 3 |
700 | 1 | _ | |a Ma, Sicong |0 P:(DE-He78)b74df323e3939b563635a2cba7a7afba |b 4 |u dkfz |
700 | 1 | _ | |a Wu, Jingxia |0 P:(DE-He78)bf88e5f49a614f52ba8ce2cd433e6b41 |b 5 |u dkfz |
700 | 1 | _ | |a Mieg, Alessa |0 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d |b 6 |u dkfz |
700 | 1 | _ | |a Hering, Marvin |0 P:(DE-He78)b099c4255c1bff642f4d338ef157596e |b 7 |u dkfz |
700 | 1 | _ | |a Ming, Yanan |0 P:(DE-He78)8ce8b1ff87fe0b01dfcbdb9d2b22046d |b 8 |u dkfz |
700 | 1 | _ | |a Mohr, Kerstin |0 P:(DE-He78)6c644df06759d9295db52a00eac44c0f |b 9 |u dkfz |
700 | 1 | _ | |a Bosch, Nora |0 P:(DE-HGF)0 |b 10 |
700 | 1 | _ | |a Cui, Guoliang |0 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b |b 11 |e Last author |u dkfz |
773 | _ | _ | |a 10.1002/ijc.34059 |g p. ijc.34059 |0 PERI:(DE-600)1474822-8 |n 5 |p 797-808 |t International journal of cancer |v 151 |y 2022 |x 0020-7136 |
909 | C | O | |o oai:inrepo02.dkfz.de:180150 |p VDB |p OpenAPC |p openCost |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)f05eabc961bc296c088b3510d6429d02 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)b74df323e3939b563635a2cba7a7afba |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)bf88e5f49a614f52ba8ce2cd433e6b41 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)b099c4255c1bff642f4d338ef157596e |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)8ce8b1ff87fe0b01dfcbdb9d2b22046d |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)6c644df06759d9295db52a00eac44c0f |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2021-02-04 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-04 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-04 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-04 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-25 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-25 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b INT J CANCER : 2021 |d 2022-11-25 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b INT J CANCER : 2021 |d 2022-11-25 |
915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
920 | 2 | _ | |0 I:(DE-He78)D192-20160331 |k D192 |l T-Zell-Metabolismus |x 0 |
920 | 1 | _ | |0 I:(DE-He78)D192-20160331 |k D192 |l T-Zell-Metabolismus |x 0 |
920 | 0 | _ | |0 I:(DE-He78)D192-20160331 |k D192 |l T-Zell-Metabolismus |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D192-20160331 |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a APC |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|